ArticleBMC oral health2025
Prevalence and risk factors for oral human papillomavirus and Epstein-Barr virus co-infections among sexually active males and females in Ibadan, Nigeria.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pattern of Oral Sexual Behaviour and Oral Health Among People Living With HIV/AIDS in Ibadan, Nigeria.Journal of the International Association of Providers of AIDS CareArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCo-infection of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) is associated with oral and oropharyngeal cancers. This study examined the prevalence and associated risk factors for oral HPV and EBV co-infection among sexually active individuals in Nigeria.
methodsThis was a secondary analysis of oral samples of some selected participants in the Sexual Behaviour and HPV Infection in Nigerians in Ibadan (SHINI) study. Stored oral samples were analysed for detection of EBV DNA using real-time PCR detection and quantification kits. The socio-demographic characteristics, lifestyle and sexual behaviours, and biological characteristics, including the HPV genotype results, were retrieved from the SHINI study data. The association between oral HPV and EBV co-infection and selected participants' characteristics were examined with chi-square or Fisher exact tests. Unadjusted logistic regression and multivariable hierarchical logistic regressions were performed to identify the significant risk factors with HPV and EBV co-infection. Statistical significance was set at p < 0.05.
resultsIn total, 104 oral samples were analysed. The prevalence of oral HPV and EBV co-infection was 26.9%. Half (50%) of these participants were positive for EBV, and 45.2% were positive for oral HPV only. Nearly all participants with oral HPV and EBV co-infection were females (96.4%). Sex (p = 0.008), anal HPV infection (p < 0.001), genital HPV (p = 0.002), and HIV status (p = 0.004) were significantly associated with the co-infection. The odds of oral HPV and EBV co-infection was lower among males [ aOR = 0.11, 95% CI: 0.00-14.51].
conclusionThere is high prevalence of oral HPV and EBV co-infection in males and females in Nigeria, with HIV status identified as a significant risk factor. Targeted public health measures, such as HPV vaccination programs especially in high-risk groups are recommended to reduce the burden of oral HPV and EBV co-infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.